The Journal of the American Dental Association
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Am Dent Assoc, Vol 139, No 2, 152-157.
© 2008 American Dental Association

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Mandel, L.
Right arrow Articles by Alfi, D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mandel, L.
Right arrow Articles by Alfi, D.

CLINICAL PRACTICE

Drug-induced paraparotid fat deposition in patients with HIV

Case reports



Louis Mandel, DDS and David Alfi, DDS

Background. The treatment of patients with HIV is managed effectively with highly active antiretroviral therapy, but complications in the form of a lipodystrophy syndrome (LDS) often develop.

Case Descriptions. The authors describe two patients who had bilateral parotid area fatty swellings, which are a manifestation of the fat redistribution seen in LDS. Fat hypertrophy, fat atrophy or both in other regions; dyslipidemia; and glucose abnormalities also were present.

Conclusion and Clinical Implications. Although the LDS in patients with HIV is recognized visibly by fat redistribution, the syndrome includes dyslipidemia and insulin resistance. Dental visits give dentists the opportunity to recognize HIV-related cervicofacial fat alterations. For appropriate attention, referral to the patient’s physician who is managing the HIV is indicated.

Key Words: Paraparotid fat; lipodystrophy; lipodystrophy syndrome; highly active antiretroviral therapy

Abbreviations: CT: Computed tomography. • DILS: Diffuse infiltrative CD8 lymphocytosis syndrome. • HAART: Highly active antiretroviral therapy. • LD: Lipodystrophy. • LDS: Lipodystrophy syndrome. • NRTI: Nucleoside reverse transcriptase inhibitor. • PI: Protease inhibitor. • SGC: Salivary Gland Center.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright©1995-2008 American Dental Association (ADA).
Reproduction or republication strictly prohibited without prior written permission of ADA.